Navigation Links
Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
Date:5/21/2008

, we see a clear opportunity for this drug in the first-line treatment of older patients who may not benefit from standard induction therapy," said Daniel C. Adelman, M.D., Senior Vice President, Development and Chief Medical Officer of Sunesis. "Treatment options for elderly AML patients are extremely limited. If the data from this trial indicate clear clinical benefit, Sunesis could initiate a pivotal trial in this highly underserved patient population. We expect to present interim data from this trial at a medical conference toward the end of this year."

Sunesis previously reported promising results from its Phase 1 single agent dose-escalation study of voreloxin in relapsed or refractory AML patients. In that trial, 13 of 30 patients (43 percent) who received doses of voreloxin of 50 mg/m2 or greater on a weekly dose schedule achieved bone marrow blast reductions to less than five percent, and five of those 13 achieved either CR, CRp or complete remission with incomplete recovery of normal hematopoietic blood elements. Voreloxin was generally well tolerated, with a dose-limiting toxicity of reversible oral mucositis. A maximum- tolerated weekly dose of 72 mg/m2 was established.

Sunesis also announced today that voreloxin has been accepted as the nonproprietary name for SNS-595 by the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee. Although voreloxin has been officially accepted by the USAN Council, the official adoption date has been set for May 28, 2008. The USAN Council serves health professionals in the United States by selecting simple, informative, and unique nonproprietary names for drugs by establishing logical nomenclature classifications based on pharmacological and/or chemical relationships to ensure that drug information is communicated accurately and unambiguously. The USAN Council aims for global standardization and unification of
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
2. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
3. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
4. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
5. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
8. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
9. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
10. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
11. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
(Date:1/23/2015)... , Jan. 23, 2015  Now available for sale, The ... support that prevents ankle sprains by cushioning the ankle ... fits securely around the outside of any shoe type ... comfort while still offering protection against sprains. With customers ...
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ( ... or the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, ... today, and provides an update for shareholders detailing why a ... requested. Dear Shareholders, As we reflect ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... , May 7 Speedway Children,s Charities and the ... to deliver the gift of hearing to more than 70 underserved children ... to 4pm , at Charlotte Motor Speedway.  Members of the ... welcome by Justin Osmond at 11:00am in the "Victory ...
... Each morning, Margaret Adkins rolls from the bedroom in her apartment to the ... may visit with a friend in their senior citizens complex. Her morning activities are possible ... , , ... , Adkins, 70, had a ...
Cached Medicine Technology:The Gift of Hearing Will be Delivered Free to Over 75 Beneficiaries, as Speedway Children's Charities and the Starkey Hearing Foundation Host 'Get in Gear to Help Children Hear' 2Power Mobility: Independence and Joy for Medicare Patients 2Power Mobility: Independence and Joy for Medicare Patients 3Power Mobility: Independence and Joy for Medicare Patients 4
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... Model Significantly Improves Patient OutcomesEL SEGUNDO, Calif., March ... kidney care services for those diagnosed with chronic ... a study revealing DaVita,s IMPACT(TM) (Incident Management of ... significantly reduce mortality rates for new dialysis patients. ...
... such as those in Iraq and Afghanistan can be ... multidrug resistant bacteria. The potentially lethal microbes include superbugs ... Acinetobacter baumannii , Pseudomonas aeruginosa , ... K. Murray, from Brooke Army Medical Center, USA, told ...
... repair complex heart defects with a survival rate of ... a happy ending for these children and teens. ... others, with the same condition, may not. , A ... United States shows that several categories of patients with ...
... cut risk by 43 percent, study found , , SUNDAY, ... reducing the incidence of heart attacks and stroke, the ... reducing the rate of blood clots in the veins, ... study, being presented Sunday at the American College of ...
... The allergen breathed in by a person with asthma ... cascade of events to prompt an allergic reaction, said a ... www.bcm.edu ) in Houston in a report that appears online ... particular, MMP7 activates interleukin 25, a key mediator of the ...
... out, projects require care and caution , , SUNDAY, March 29 ... and yard work -- but if they,re not careful, it ... Mishaps with ladders, gardening tools and lawn mowers alone cause ... attention, according to the U.S. Consumer Product Safety Commission. Many ...
Cached Medicine News:Health News:DaVita's IMPACT Program Reduces Mortality for New Dialysis Patients 2Health News:DaVita's IMPACT Program Reduces Mortality for New Dialysis Patients 3Health News:Physicians mending broken hearts 2Health News:Statin Might Help Fight Blood Clots in Veins 2Health News:Statin Might Help Fight Blood Clots in Veins 3Health News:Tips to Avoid Spring Cleaning Mishaps 2
... is our most popular Low ... It offers a wide field ... and hence a slightly shorter ... be mounted to virtually and ...
The Redi-glaze spectacle magnifier is an aspheric lens, glazed into a standard Keeler LVA frame....
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
Medicine Products: